UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 59

Sortiert nach

Exercise lowers estrogen and progesterone levels in premenopausal women at high risk of breast cancer

Journal of applied physiology (1985), 2011-12, Vol.111 (6), p.1687-1693

2011

Volltextzugriff (PDF)

Breast cancer risks in individuals testing negative for a known family mutation in BRCA1 or BRCA2

Breast cancer research and treatment, 2010-01, Vol.119 (2), p.409-414

2010

Volltextzugriff (PDF)

Non-cancer endpoints in BRCA1/2 carriers after risk-reducing salpingo-oophorectomy

Familial cancer, 2012-03, Vol.11 (1), p.69-75

2012

Volltextzugriff (PDF)

Effect of Genetic Counseling and Testing for BRCA1 and BRCA2 Mutations in African American Women: A Randomized Trial

Public health genomics, 2010-01, Vol.13 (7/8), p.440-448

2010

Volltextzugriff (PDF)

Assessment and counseling for women with a family history of breast cancer. A guide for clinicians

JAMA : the journal of the American Medical Association, 1995-02, Vol.273 (7), p.577

1995

Volltextzugriff (PDF)

Genetic counseling in oncology

JAMA : the journal of the American Medical Association, 2011-10, Vol.306 (13), p.1442; author reply 1442

2011

Volltextzugriff (PDF)

Cancer Risk Estimates for BRCA1 Mutation Carriers Identified in a Risk Evaluation Program

JNCI : Journal of the National Cancer Institute, 2002-09, Vol.94 (18), p.1365-1372

2002

Volltextzugriff (PDF)

Genetic counseling and clinical cancer genetics services

Seminars in surgical oncology, 2000-06, Vol.18 (4), p.347-357

Stopfer, Jill E.

2000

Volltextzugriff (PDF)

Factors determining dissemination of results and uptake of genetic testing in families with known BRCA1/2 mutations

Genetic testing, 2008-03, Vol.12 (1), p.81

2008

Volltextzugriff (PDF)

Recruiting African American Women to Participate in Hereditary Breast Cancer Research

Journal of clinical oncology, 2005-11, Vol.23 (31), p.7967-7973

2005

Volltextzugriff (PDF)

Breast cancer risks in individuals testing negative for known family mutations in BRCA1 or BRCA2

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.11044-11044

2009

Volltextzugriff (PDF)

Childhood cancer in families with and without germline BRCA1/2 mutations ascertained at a high-risk breast cancer clinic

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.10013-10013

2006

Volltextzugriff (PDF)

Characterization of two novel BRCA1 germ-line mutations involving splice donor sites

Genetic testing, 2004-06, Vol.8 (2), p.133-138

2004

Volltextzugriff (PDF)

Genetic counseling for BRCA1 and BRCA2 mutations in African American women

Cancer research (Chicago, Ill.), 2009-01, Vol.69 (2_Supplement), p.1099

2009

Volltextzugriff (PDF)

Factors that influence genetic testing outcomes in high-risk breast/ovarian families

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.9616-9616

2005

Volltextzugriff (PDF)

Comprehensive 4-year follow-up on a case of maternal heterodisomy for chromosome 16

American journal of medical genetics, 1996-12, Vol.66 (2), p.204-208

1996

Volltextzugriff (PDF)

Role of the genetic counselor in familial cancer

Oncology (Williston Park, N.Y.), 1996-02, Vol.10 (2), p.159

1996

Volltextzugriff (PDF)

Complexities in Cancer Risk Counseling: Presentation of Three Cases

Journal of genetic counseling, 1997-06, Vol.6 (2), p.147-167

1997

Volltextzugriff (PDF)

Acceptance of invitations for p53 and BRCA1 predisposition testing: Factors influencing potential utilization of cancer genetic testing

Psycho-oncology (Chichester, England), 1996-09, Vol.5 (3), p.241-250

1996

Volltextzugriff (PDF)

Accuracy of cancer family histories: comparison of two breast cancer syndromes

Genetic testing, 2004, Vol.8 (3), p.222-228

2004

Volltextzugriff (PDF)

Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis

American journal of physiology. Lung cellular and molecular physiology, 2015-02, Vol.308 (4), p.L344-L357

2015

Volltextzugriff (PDF)

MEK inhibition enhances presentation of targetable MHC-I tumor antigens in mutant melanomas

Nevada RNformation, 2022-12, Vol.119 (49), p.e2208900119

2022

Volltextzugriff (PDF)

Absolute quantification of tumor antigens using embedded MHC-I isotopologue calibrants

Proceedings of the National Academy of Sciences - PNAS, 2021-09, Vol.118 (37)

2021

Volltextzugriff (PDF)

Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer

JAMA : the journal of the American Medical Association, 2005-04, Vol.293 (14), p.1729

2005

Volltextzugriff (PDF)

A Randomized Trial of Two Remote Health Care Delivery Models on the Uptake of Genetic Testing and Impact on Patient-Reported Psychological Outcomes in Families With Pancreatic Cancer: The Genetic Education, Risk Assessment, and Testing (GENERATE) Study

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.872-885.e2

2024

Volltextzugriff (PDF)

1 – 25 von 59

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(55)
Mit Volltextzugriff
(53)

Publikationsform

Artikel
(59)

Sprache

Englisch
(59)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Exercise lowers estrogen and progesterone levels in premenopausal women at high risk of breast cancer

Breast cancer risks in individuals testing negative for a known family mutation in BRCA1 or BRCA2

Non-cancer endpoints in BRCA1/2 carriers after risk-reducing salpingo-oophorectomy

Effect of Genetic Counseling and Testing for BRCA1 and BRCA2 Mutations in African American Women: A Randomized Trial

Assessment and counseling for women with a family history of breast cancer. A guide for clinicians

Genetic counseling in oncology

Cancer Risk Estimates for BRCA1 Mutation Carriers Identified in a Risk Evaluation Program

Genetic counseling and clinical cancer genetics services

Factors determining dissemination of results and uptake of genetic testing in families with known BRCA1/2 mutations

Recruiting African American Women to Participate in Hereditary Breast Cancer Research

Breast cancer risks in individuals testing negative for known family mutations in BRCA1 or BRCA2

Childhood cancer in families with and without germline BRCA1/2 mutations ascertained at a high-risk breast cancer clinic

Characterization of two novel BRCA1 germ-line mutations involving splice donor sites

Genetic counseling for BRCA1 and BRCA2 mutations in African American women

Factors that influence genetic testing outcomes in high-risk breast/ovarian families

Comprehensive 4-year follow-up on a case of maternal heterodisomy for chromosome 16

Role of the genetic counselor in familial cancer

Complexities in Cancer Risk Counseling: Presentation of Three Cases

Acceptance of invitations for p53 and BRCA1 predisposition testing: Factors influencing potential utilization of cancer genetic testing

Accuracy of cancer family histories: comparison of two breast cancer syndromes

Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis

MEK inhibition enhances presentation of targetable MHC-I tumor antigens in mutant melanomas

Absolute quantification of tumor antigens using embedded MHC-I isotopologue calibrants

Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer

A Randomized Trial of Two Remote Health Care Delivery Models on the Uptake of Genetic Testing and Impact on Patient-Reported Psychological Outcomes in Families With Pancreatic Cancer: The Genetic Education, Risk Assessment, and Testing (GENERATE) Study

Suchergebnisse filtern